Search Results - "scleroderma systematica"

Search alternatives:

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
    NEW CLASSIFICATION CRITERIA FOR SCLERODERMA SYSTEMATICA (a lecture)

    NEW CLASSIFICATION CRITERIA FOR SCLERODERMA SYSTEMATICA (a lecture) by Lidia Petrovna Ananyeva

    Published 2013-12-01
    Subjects: “…scleroderma systematica…”
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    IMPORTANCE OF CYCLOPHOSPHANUM IN THE TREATMENT OF INTERSTITIAL LUNG LESION IN PATIENTS WITH SCLERODERMA SYSTEMATICA (A REVIEW OF LITERATURE)

    IMPORTANCE OF CYCLOPHOSPHANUM IN THE TREATMENT OF INTERSTITIAL LUNG LESION IN PATIENTS WITH SCLERODERMA SYSTEMATICA (A REVIEW OF LITERATURE) by Olga Aleksandrova Koneva

    Published 2010-06-01
    Subjects:
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    PROSPECTS FOR USING TOCILIZUMAB IN SYSTEMIC SCLEROSIS

    PROSPECTS FOR USING TOCILIZUMAB IN SYSTEMIC SCLEROSIS by L. P. Ananyeva

    Published 2016-02-01
    Subjects: “…scleroderma systematica…”
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    COMPLEX THERAPY FOR VASCULAR DISORDERS IN PATIENTS WITH SCLERODERMA SYSTEMATICA

    COMPLEX THERAPY FOR VASCULAR DISORDERS IN PATIENTS WITH SCLERODERMA SYSTEMATICA by M N Starovoitova, O V Desinova, A V Volkov

    Published 2009-06-01
    Subjects: “…scleroderma systematica…”
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    Diagnosis and treatment of interstitial lung disease in scleroderma systematica

    Diagnosis and treatment of interstitial lung disease in scleroderma systematica by L. P. Ananyeva

    Published 2018-06-01
    Subjects: “…scleroderma systematica…”
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    SCLERODERMA SYSTEMATICA WITH INTERSTITIAL LUNG LESION: COMPARATIVE CLINICAL CHARACTERISTICSWITH PATIENTS WITHOUT LUNG LESION

    SCLERODERMA SYSTEMATICA WITH INTERSTITIAL LUNG LESION: COMPARATIVE CLINICAL CHARACTERISTICSWITH PATIENTS WITHOUT LUNG LESION by Lyudmila Valeryevna Teplova, L P Ananyeva, V N Lesnyak, M N Starovoitova, O V Desinova, T A Nevskaya, E N Aleksandrova

    Published 2010-06-01
    Subjects: “…scleroderma systematica…”
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    Microcirculatory disorders in scleroderma systematica: an association with vascular wall stiffness

    Microcirculatory disorders in scleroderma systematica: an association with vascular wall stiffness by Ulyana Yuryevna Ruzhentsova

    Published 2013-06-01
    Subjects: “…scleroderma systematica…”
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    Positivity for antiribonucleoprotein antibodies in rheumatic diseases: focus on scleroderma systematica

    Positivity for antiribonucleoprotein antibodies in rheumatic diseases: focus on scleroderma systematica by R. U. Shayakhmetova, L. P. Ananyeva

    Published 2018-01-01
    Subjects: “…scleroderma systematica…”
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    ESOPHAGEAL PATHOLOGY IN SCLERODERMA SYSTEMATICA: CLINICAL AND ENDOSCOPIC FINDINGS

    ESOPHAGEAL PATHOLOGY IN SCLERODERMA SYSTEMATICA: CLINICAL AND ENDOSCOPIC FINDINGS by A E Karateev, M M Movsisyan, L P Ananyeva, S G Radenska-Lopovok

    Published 2012-02-01
    Subjects: “…scleroderma systematica…”
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    Assessment of lung ultrasound in patients with scleroderma systematica and interstitial lung disease

    Assessment of lung ultrasound in patients with scleroderma systematica and interstitial lung disease by Olga Borisovna Ovsyannikova, L P Ananyeva, Yu O Korsakova, O A Koneva, A V Volkov, S I Glukhova

    Published 2013-06-01
    Subjects: “…scleroderma systematica…”
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    RITUXIMAB TREATMENT FOR INTERSTITIAL LUNG INJURY IN SCLERODERMA SYSTEMATICA

    RITUXIMAB TREATMENT FOR INTERSTITIAL LUNG INJURY IN SCLERODERMA SYSTEMATICA by Lidia Petrovna Ananieva, O V Desinova, O A Koneva, M N Starovoitova, N N Yutkina, A V Volkov, O B Ovsyannikova, A P Aleksankin, E N Aleksandrova, A A Novikov, E L Nasonov

    Published 2013-12-01
    Subjects: “…scleroderma systematica…”
    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    Characteristics of clinical, laboratory, and immunological manifestations in patients with anticentromere antibody-associated Sjögren's disease

    Characteristics of clinical, laboratory, and immunological manifestations in patients with anticentromere antibody-associated Sjögren's disease by B. D. Chaltsev, V. I. Vasilyev, S. G. Palshina, A. V. Torgashina, E. V. Sokol, Yu. I. Khvan, E. B. Rodionova, T. N. Safonova, S. V. Lapin, O. Yu. Tkachenko, A. V. Mazing

    Published 2020-11-01
    Subjects:
    Get full text
    Article

    Save to List
    Saved in:
  13. 13
    The first Russian experience with the endothelin 1 receptor inhibitor traclir used in patients with pulmonary hypertension associated with systemic connective tissue diseases

    The first Russian experience with the endothelin 1 receptor inhibitor traclir used in patients with pulmonary hypertension associated with systemic connective tissue diseases by Aleksandr Vitalyevich Volkov, T V Martynyuk, N N Yudkina, N M Danilov, T M Reshetnyak, I E Chazova, E L Nasonov

    Published 2011-12-01
    Subjects:
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: